New evidence in this week’s BMJ supports the use of up to three antiviral drugs (triple therapy) to treat people with HIV.
Researchers in Birmingham reviewed 54 trials involving over 20,000 patients with HIV infection who had not already received antiviral therapy.
Combinations of up to three drugs were consistently and significantly more effective, but there was inadequate evidence on the effectiveness of quadruple or higher combinations. There was also marked variation, mainly accounted for by the drugs tested and issues of quality, say the authors.
Further work is needed to clarify which triple combination is the most effective and to investigate the effectiveness of quadruple or higher combinations, conclude the authors.
Emma Wilkinson | Source: alphagalileo
More articles from Health and Medicine:
Polyphenols and polyunsaturated fatty acids boost the birth of new neurons
25.11.2009 | Universitat Autonoma de Barcelona
Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps
24.11.2009 | Johns Hopkins Medical Institutions
First black holes may have incubated in giant, starlike cocoons
25.11.2009 | Physics and Astronomy
KfW issues its first ever 7 year Euro-Benchmark
25.11.2009 | Business and Finance
Intelligence inside metal components
25.11.2009 | Information Technology
Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients
20.11.2009 | Event News
'Golden Age' for clinical psychology in Northern Ireland
20.11.2009 | Event News
New Perspectives in Marine Anti-Fouling Research
11.11.2009 | Event News